Advertisement

Related Videos

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Opportunities to Optimize Cancer Policies Panel Discussion

Advertisement

Advertisement




Apr
29
Today In Oncology
AI-Powered, Next-Generation Sequencing Blood-Based Assay Evaluated for Detection of Post-HCT Relapse in AML and MDS
MIBC Pembrolizumab With Trimodal Therapy for Bladder Preservation
Long-Term Outcomes With Taletrectinib in ROS1-Positive NSCLC
Amivantamab in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer
Study Finds Prostate Cancer Overdiagnosis Rises ‘Substantially’ With Age
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo